Metimedi Co., Ltd
MetiMedi, a bio pharmaceutical company based in South Korea, is at the forefront of cutting-edge research in immuno-oncology. The company is committed to developing a unique platform technology that addresses the unmet needs of solid cancer therapies and beyond. By targeting specific cellular metabolic reprogramming in tumor cells, MetiMedi's immunotherapy leads to tumor necroptosis and immune activation, with exceptional safety. Phase 2 clinical studies with METI-101 for refractory metastatic colorectal cancer have demonstrated efficacy and safety.
7-day free trial · no credit card
Verified contacts
6
available on Kipplo
LinkedIn employees
6
11 to 50 range
Open roles
—
no listings
Distinct roles
6
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 6 verified contacts at Metimedi Co., Ltd
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
6 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Metimedi Co., Ltd
6 distinct titles indexed · top 6 shown.
- 1bd manager
- 1chief scientific officer
- 1founder and chief executive officer
- 1intern
- 1team lead
- 1경영지원본부 매니저
Sign up to unlock all 6 contacts at Metimedi Co., Ltd
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 6 verified contacts at Metimedi Co., Ltd
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.